| |
| |
|
| Insider
Information: |
Mcclellan Michael James |
| Relationship: |
EVP, Chief Financial O... |
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
15,898 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$222,254 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,898 |
|
|
| Total
Value |
$222,254 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
EVP, Chief Financial O... |
2019-11-05 |
15,898 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-11-05 |
4 |
AS |
$8.83 |
$2,138 |
D/D |
(242) |
15,898 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
695 |
16,140 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-09-18 |
4 |
AS |
$7.83 |
$11,011 |
D/D |
(1,406) |
15,445 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,091 |
16,851 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-03-18 |
4 |
AS |
$16.63 |
$3,824 |
D/D |
(230) |
12,760 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
660 |
12,990 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-03-04 |
4 |
AS |
$16.88 |
$6,129 |
D/D |
(363) |
12,330 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2019-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,049 |
12,693 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2018-11-05 |
4 |
S |
$22.73 |
$7,865 |
D/D |
(346) |
11,644 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2018-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
695 |
11,990 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2018-03-19 |
4 |
S |
$17.88 |
$5,131 |
D/D |
(287) |
11,295 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2018-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
660 |
11,582 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2018-03-05 |
4 |
D |
$19.38 |
$8,818 |
D/D |
(455) |
10,922 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
EVP, Chief Financial Officer |
• – – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,049 |
11,377 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
